Orion
51.66
EUR
-1.71 %
ORNBV
NASDAQ Helsinki
Biotechnology & Pharmaceuticals
Health Care
13,909 following
Income statement
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,033.6 | 977.5 | 1,051.0 | 1,078.1 | 1,041.1 | 1,340.6 | 1,189.6 | 1,542.1 | 1,571.8 | 1,814.9 | 1,746.3 |
growth-% | -5.4 % | 7.5 % | 2.6 % | -3.4 % | 28.8 % | -11.3 % | 29.6 % | 1.9 % | 15.5 % | -3.8 % | |
EBITDA | 326.4 | 293.9 | 308.9 | 336.5 | 289.0 | 486.6 | 326.4 | 467.5 | 416.1 | 635.3 | 508.6 |
EBIT (adj.) | 284.1 | 252.8 | 252.8 | 280.1 | 243.3 | 439.6 | 274.9 | 416.5 | 372.1 | 580.8 | 454.0 |
EBIT | 284.1 | 252.8 | 252.8 | 280.1 | 243.3 | 439.6 | 274.9 | 416.5 | 372.1 | 580.8 | 454.0 |
Profit before taxes | 277.7 | 248.4 | 250.8 | 278.3 | 242.3 | 440.3 | 271.9 | 413.5 | 370.1 | 580.2 | 454.5 |
Net income | 219.1 | 197.3 | 200.4 | 219.9 | 193.8 | 349.5 | 216.8 | 329.2 | 292.4 | 458.4 | 359.1 |
EPS (adj.) | 1.40 | 1.42 | 1.57 | 1.38 | 2.49 | 1.54 | 2.34 | 2.08 | 3.26 | 2.56 | |
growth-% | 1.5 % | 9.9 % | -11.9 % | 80.3 % | -38.0 % | 51.8 % | -11.2 % | 56.8 % | -21.7 % | ||
Dividend | 0.00 | 1.50 | 1.50 | 1.50 | 1.50 | 1.60 | 1.62 | 1.65 | 1.70 | 1.75 | 1.80 |
Dividend ratio | 107.0 % | 105.3 % | 95.8 % | 108.7 % | 64.3 % | 105.0 % | 70.4 % | 81.7 % | 53.6 % | 70.4 % |
Profitability and return on capital
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|---|---|---|
EBITDA-% | 31.6 % | 30.1 % | 29.4 % | 31.2 % | 27.8 % | 36.3 % | 27.4 % | 30.3 % | 26.5 % | 35.0 % | 29.1 % |
EBIT-% (adj.) | 27.5 % | 25.9 % | 24.1 % | 26.0 % | 23.4 % | 32.8 % | 23.1 % | 27.0 % | 23.7 % | 32.0 % | 26.0 % |
EBIT-% | 27.5 % | 25.9 % | 24.1 % | 26.0 % | 23.4 % | 32.8 % | 23.1 % | 27.0 % | 23.7 % | 32.0 % | 26.0 % |
ROE | 27.2 % | 25.8 % | 29.1 % | 26.8 % | 43.1 % | 24.1 % | 35.0 % | 28.6 % | 39.4 % | 27.0 % | |
ROI | 27.4 % | 29.5 % | 34.4 % | 29.5 % | 45.6 % | 24.9 % | 37.5 % | 32.9 % | 48.3 % | 34.2 % |
Valuation
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Share price (EUR) | 27.35 | 32.51 | 42.50 | 40.95 | 36.66 | 49.70 | 37.50 | 51.66 | 51.66 | 51.66 | 51.66 |
Shares | 140.7 | 140.7 | 140.5 | 140.5 | 140.5 | 140.5 | 140.5 | 140.5 | 140.5 | 140.5 | |
Market cap | 4,574.0 | 5,979.6 | 5,752.0 | 5,149.4 | 6,981.0 | 5,267.4 | 7,256.3 | 7,256.3 | 7,256.3 | 7,256.3 | |
Enterprise value | 4,441.9 | 5,840.6 | 5,566.2 | 4,960.0 | 6,862.4 | 5,360.7 | 7,257.5 | 7,196.6 | 7,036.7 | 6,878.8 | |
EV/S | - | 4.5 | 5.6 | 5.2 | 4.8 | 5.1 | 4.5 | 4.7 | 4.6 | 3.9 | 3.9 |
EV/EBITDA | - | 15.1 | 18.9 | 16.5 | 17.2 | 14.1 | 16.4 | 15.5 | 17.3 | 11.1 | 13.5 |
EV/EBIT (adj.) | - | 17.6 | 23.1 | 19.9 | 20.4 | 15.6 | 19.5 | 17.4 | 19.3 | 12.1 | 15.2 |
EV/EBIT | - | 17.6 | 23.1 | 19.9 | 20.4 | 15.6 | 19.5 | 17.4 | 19.3 | 12.1 | 15.2 |
P/E (adj.) | - | 23.2 | 29.8 | 26.2 | 26.6 | 20.0 | 24.3 | 22.0 | 24.8 | 15.8 | 20.2 |
P/E | - | 23.2 | 29.8 | 26.2 | 26.6 | 20.0 | 24.3 | 22.0 | 24.8 | 15.8 | 20.2 |
P/B | - | 5.9 | 7.7 | 7.9 | 7.2 | 7.7 | 5.9 | 7.3 | 6.9 | 5.7 | 5.2 |
P/S | - | 4.7 | 5.7 | 5.3 | 4.9 | 5.2 | 4.4 | 4.7 | 4.6 | 4.0 | 4.2 |
Dividend yield | 4.6 % | 3.5 % | 3.7 % | 4.1 % | 3.2 % | 4.3 % | 3.2 % | 3.3 % | 3.4 % | 3.5 % | |
Equity ratio | 64.4 % | 67.4 % | 75.3 % | 65.6 % | 66.0 % | 60.4 % | 61.9 % | 65.8 % | 69.6 % | 76.2 % | 77.9 % |
Gearing ratio | 11.6 % | -17.1 % | -17.8 % | -25.4 % | -26.5 % | -13.1 % | 10.5 % | 0.1 % | -5.7 % | -17.3 % | -27.3 % |
Quarter data
Q4/23 | 2023 | Q1/24 | Q2/24 | Q3/24 | Q4/24e | 2024e | Q1/25e | Q2/25e | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 321.1 | 1,189.6 | 308.5 | 328.2 | 471.3 | 434.1 | 1,542.1 | ||
EBITDA | 106.6 | 326.4 | 67.0 | 80.3 | 215.0 | 105.2 | 467.5 | 81.6 | 93.2 |
EBIT | 92.9 | 274.9 | 56.0 | 65.8 | 202.0 | 92.7 | 416.5 | 70.6 | 82.2 |
Profit before taxes | 92.5 | 271.9 | 54.9 | 65.1 | 201.4 | 92.1 | 413.5 | 70.6 | 82.2 |
Net income | 75.2 | 216.8 | 43.7 | 52.0 | 160.7 | 72.8 | 329.2 | 70.6 | 82.2 |